MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.560
+0.010 (0.65%)
At close: Dec 5, 2025, 4:00 PM EST
1.510
-0.050 (-3.21%)
After-hours: Dec 5, 2025, 7:41 PM EST
MediciNova Revenue
MediciNova had revenue of $123.32K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $257.92K.
Revenue (ttm)
$257.92K
Revenue Growth
n/a
P/S Ratio
296.69
Revenue / Employee
$19,840
Employees
13
Market Cap
76.51M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
MNOV News
- 17 days ago - MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor - GlobeNewsWire
- 4 weeks ago - MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards - GlobeNewsWire
- 5 weeks ago - MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication - GlobeNewsWire
- 2 months ago - MediciNova to Present at the LD Micro Main Event XIX Investor Conference - GlobeNewsWire
- 3 months ago - MediciNova Provides Shareholder Update on Key Developments - GlobeNewsWire
- 3 months ago - MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial - GlobeNewsWire
- 4 months ago - MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million - GlobeNewsWire